Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
Randomized Clinical Trial of Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium in Reducing Pain During Office Hysteroscopy
Sponsor: Assiut University
Listed as NCT02714699, this PHASE2/PHASE3 trial focuses on Endoscopy and remains completed. Sponsored by Assiut University, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2017 — Aug 2017 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .